The first patient completed treatment with the Russian cancer vaccine.
The scientific director of the Gamaliya Center, Academy of the Russian Academy of Sciences, Alexander Ginzburg, said that the metastases previously discovered in the patient disappeared, and for four months his condition did not cause concern. According to the academy, the patient is under monthly follow-up.
"Knock on wood: It looks like it's been four months and he's doing great," Gunzburg said.
At the same time, the medical observation of the patient will probably continue for three years, so that experts can monitor their health after the end of the treatment. Currently, six people have already received the Russian cancer vaccine. It is built on mRNA technology: the vaccine adjusts the patient's immunity so that it destroys the tumor and its metastases independently. The medicine is created individually for each patient.